Gateway Advisory’s iShares Biotechnology ETF IBB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-74,490
Closed -$10.2M 144
2024
Q1
$10.2M Buy
74,490
+2,139
+3% +$292K 1.79% 12
2023
Q4
$9.83M Buy
+72,351
New +$8.83M 1.89% 13
2014
Q1
Sell
-4,233
Closed -$320K 47
2013
Q4
$320K Buy
+4,233
New +$300K 0.18% 33

Other funds holding IBB

Gateway Advisory's IBB Position: Q2 2024 in Review

Gateway Advisory sold out of iShares Biotechnology ETF (IBB) in Q2 2024, closing a stake of 74,490 shares — an estimated $10.2M sold.

Gateway Advisory first reported a position in IBB in Q4 2013 and held it in 3 quarters. The position peaked at $10.2M in Q1 2024. 894 funds tracked by Wall St. Rank hold IBB as of Q2 2024.

  • Gateway Advisory reported no remaining iShares Biotechnology ETF position as of Q2 2024 after selling out during the quarter.
  • Gateway Advisory sold 74,490 iShares Biotechnology ETF shares in Q2 2024, an estimated $10.2M.
  • Gateway Advisory first reported a position in iShares Biotechnology ETF in Q4 2013 and held it in 3 quarters.
  • Gateway Advisory's iShares Biotechnology ETF position peaked at $10.2M in Q1 2024.
  • 894 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2024.

Based on Gateway Advisory's 13F filing for Q2 2024, filed 14 Aug 2024.